xiaoyun wu

Dr. xiaoyun wu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SWShuyi Wang
Shuyi Wang
XXXiaotian Xu
Xiaotian Xu
CPChuxin Pan
Chuxin Pan
QGQian Guo
Qian Guo
QLQinlan Li
Qinlan Li
XWxiaoyun wu
xiaoyun wu
Epidermal growth factor receptor (EGFR) inhibitors have been used in clinical for the treatment of non-small-cell lung cancer for years. However, the emergence of drug resistance continues to be a major problem. To identify potential inhibitors, molecular docking-based virtual screening was conducted on ChemDiv and Enamine commercial databases using the Glide program. After multi-step VS and visual inspection, a total of 23 compounds with novel and varied structures were selected, and the predicted ADMET properties were within the satisfactory range. Further molecular dynamics simulations revealed that the reprehensive compound ZINC49691377 formed a stable complex with the allosteric pocket of EGFR and exhibited conserved hydrogen bond interactions with Lys 745 and Asp855 of EGFR over the course of simulation. All compounds were further tested in experiments. Among them, the most promising hit ZINC49691377 demonstrated excellent anti-proliferation activity against H1975 and PC-9 cells, while showing no significant anti-proliferation activity against A549 cells. Meanwhile, apoptosis analysis indicated that the compound ZINC49691377 can effectively induce apoptosis of H1975 and PC-9 cells in a dose-dependent manner, while having no significant effect on the apoptosis of A549 cells. The results indicate that ZINC49691377 exhibits good selectivity. Based on virtual screening and bioassays, ZINC4961377 can be considered as an excellent starting point for the development of new EGFR inhibitors.

12 August 2025 in Bioorganic Chemistry
Verified
Journal Article
Closed access
XXXiaotian Xu
Xiaotian Xu
HHHuan He
Huan He
QGQian Guo
Qian Guo
SWShanhe Wan
Shanhe Wan
ZLZhonghuang Li
Zhonghuang Li
XWxiaoyun wu
xiaoyun wu

26 March 2026 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
XXXiaotian Xu
Xiaotian Xu
YWYongbo Wei
Yongbo Wei
HHHuan He
Huan He
SWShanhe Wan
Shanhe Wan
ZLZhonghuang Li
Zhonghuang Li
XWxiaoyun wu
xiaoyun wu

25 July 2026 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
YWYongbo Wei
Yongbo Wei
HHHuan He
Huan He
XWxiaoyun wu
xiaoyun wu